An initial blueprint for myogenic differentiation

  1. Alexandre Blais1,
  2. Mary Tsikitis1,
  3. Diego Acosta-Alvear1,
  4. Roded Sharan2,
  5. Yuval Kluger3, and
  6. Brian David Dynlacht1,4
  1. 1Department of Pathology, New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA; 2School of Computer Science, Tel-Aviv University, Tel-Aviv 69978, Israel; 3Skirball Institute of Biomolecular Medicine, New York University, New York, New York 10016, USA

Abstract

We have combined genome-wide transcription factor binding and expression profiling to assemble a regulatory network controlling the myogenic differentiation program in mammalian cells. We identified a cadre of overlapping and distinct targets of the key myogenic regulatory factors (MRFs)—MyoD and myogenin—and Myocyte Enhancer Factor 2 (MEF2). We discovered that MRFs and MEF2 regulate a remarkably extensive array of transcription factor genes that propagate and amplify the signals initiated by MRFs. We found that MRFs play an unexpectedly wide-ranging role in directing the assembly and usage of the neuromuscular junction. Interestingly, these factors also prepare myoblasts to respond to diverse types of stress. Computational analyses identified novel combinations of factors that, depending on the differentiation state, might collaborate with MRFs. Our studies suggest unanticipated biological insights into muscle development and highlight new directions for further studies of genes involved in muscle repair and responses to stress and damage.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1281105.

  • 4 Corresponding author. E-MAIL brian.dynlacht{at}med.nyu.edu; FAX (212) 263-6157.

    • Accepted January 13, 2005.
    • Received November 18, 2004.
| Table of Contents

Life Science Alliance